CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-08 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Grant or award · Stock Options (right to buy) | +136,000 | 136,000 | ||
| 2022-12-08 | Prichard Heather Ledbetter Chief Operating Officer | Grant or award · Stock Options (right to buy) | +136,000 | 136,000 | ||
| 2022-12-08 | Parikh Shamik J Chief Medical Officer | Grant or award · Stock Options (right to buy) | +91,120 | 91,120 | ||
| 2022-12-08 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +444,500 | 444,500 | ||
| 2022-12-08 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +444,500 | 444,500 | ||
| 2022-09-19 | Cao Yang Chief Regulatory Officer | Grant or award · Stock Options (right to buy) | +145,000 | 145,000 | ||
| 2022-09-15 | Niklason Laura E President, CEO and Director | Purchase | +2,000 | $4.14 | $8K | 1,160,240 |
| 2022-09-15 | Dougan Brady W Director | Purchase | +2,000 | $4.14 | $8K | 1,160,240 |
| 2022-09-15 | Green Charles Bruce Director | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | ||
| 2022-09-15 | Niklason Laura E President, CEO and Director | Sale | −1,522,500 | $4.00 | $6.1M | 18,930,004 |
| 2022-09-15 | Dougan Brady W Director | Sale | −1,522,500 | $4.00 | $6.1M | 18,930,004 |
| 2022-09-15 | Ayabudge LLC 10% owner | Sale | −1,522,500 | $4.00 | $6.1M | 18,930,004 |
| 2022-09-02 | Binder Gordon M Director | Purchase | +61,841 | $4.40 | $272K | 110,000 |
| 2022-09-01 | Binder Gordon M Director | Purchase | +48,159 | $4.00 | $193K | 48,159 |
| 2022-06-09 | Binder Gordon M Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2022-06-09 | Sebelius Kathleen Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2022-06-09 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2022-06-09 | Shukla Rajiv Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2022-06-09 | Wallace Max N. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2022-06-09 | Windham-Bannister Susan Richards Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 |
Page 12 of 17 · 330 trades